If Moderna Inc’s Covid-19 vaccine proves to be at least 70 per cent effective, the company plans to seek emergency authorisation for its use in high-risk groups, the company’s chief execut...

...

Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country while revoking i...

A senior Chinese health official said a coronavirus vaccine could be available to the public in China as early as November, the state news media reported on Tuesday. Dr Wu Guizhen, the chief expert f...

...

Seven months into the coronavirus crisis, with more than 30 vaccines rapidly advancing through the rigorous stages of clinical trials, surprisingly, several research groups are placing bets on some th...

AstraZeneca has resumed British clinical trials of its Covid-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. Th...

A homegrown Indian vaccine candidate has successfully protected rhesus monkeys from the novel coronavirus disease, government and industry scientists have said, describing its immune response and prot...

The Pune-based Serum Institute of India said on Thursday that it would suspend its clinical trials of the Oxford candidate vaccine against the coronavirus disease, a day after the central drug regulat...

...